Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.69 |
| ▸ | MAOB | P27338 | 5/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.69 |
| ▸ | SDHA | P31040 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | CALML3 | P27482 | 1/20 | 0.69 |
| ▸ | F10 | P00742 | 6/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6974073 | 1.00 | MAOA (0.69) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6973747 | 0.93 | MAOA (0.69) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6970925 | 0.93 | MAOA (0.69) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6976519 | 0.91 | MAOA (0.71) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6975181 | 0.91 | MAOA (0.71) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6969860 | 0.91 | MAOA (0.66) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6969868 | 0.91 | MAOA (0.66) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6966459 | 0.90 | MAOA (0.69) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6974121 | 0.89 | MAOA (0.73) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL6971157 | 0.89 | MAOA (0.73) | MAOAMAOBPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7892574-B2 | In situ applying oxazolidinone to ear, skins | PHARMACIA & UPJOHN COMPANY, LLC (US) | 2011-02-22 | — | — | US | claimed |
| US-7128928-B2 | Ophthalmic formulation with novel gum composition | PHARMACIA CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| WO-2006079896-A2 | STABLE POLYOL FORMULATIONS OF OXAZOLIDINONE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-08-03 | — | — | WO | claimed |
| WO-2006059221-A2 | TOPICAL HYDRO-ALCOHOLIC FORMULATIONS OF OXAZOLIDINONE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-06-08 | — | — | WO | claimed |
| US-6989381-B2 | Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading | PHARMACIA CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| EP-1610764-A1 | TASTE-MASKING VEHICLE FOR COATED OXAZOLIDINONE PARTICLES | Pharmacia Corporation (US) | 2006-01-04 | — | — | EP | claimed |
| EP-1311296-B1 | SOLUTION OF AN OXAZOLIDINONE ANTIBIOTIC DRUG | PHARMACIA CORP (US) | 2005-12-14 | — | — | EP | claimed |
| EP-1096934-B1 | OXAZOLIDINONES TO TREAT EYE INFECTIONS | PHARMACIA & UPJOHN CO LLC (US) | 2005-09-21 | — | — | EP | claimed |
| EP-1304107-B1 | Use of oxazolidinines derivatives for treating psoriasis | PHARMACIA & UPJOHN CO LLC (US) | 2005-07-06 | — | — | EP | claimed |
| EP-1476135-A1 | OPHTHALMIC FORMULATION WITH GUM SYSTEM | Pharmacia Corporation (US) | 2004-11-17 | — | — | EP | claimed |
| US-20020065280-A1 | Oxazolidinones to treat eye infections | COCHRAN ROBERT J (US) | 2002-05-30 | — | — | US | claimed |
| WO-2002030395-A1 | TOPICAL ANTIBIOTIC COMPOSITION FOR TREATMENT OF EYE INFECTION | PHARMACIA & UPJOHN COMPANY (US) | 2002-04-18 | — | — | WO | claimed |
| WO-2002015940-A2 | SOLUTION OF AN OXAZOLIDINONE ANTIBIOTIC DRUG | PHARMACIA CORPORATION (US) | 2002-02-28 | — | — | WO | claimed |
| US-20020009483-A1 | TOPICAL ADMINISTRATION OF OXAZOLIDINONES FOR TRANSDERMAL DELIVERY | PHARMACIA & UPJOHN COMPANY | 2002-01-24 | — | — | US | claimed |
| EP-1032386-A1 | USE OF OXAZOLIDINONE DERIVATITIVES FOR TREATING PSORIASIS, ARTHRITIS AND REDUCING THE TOXICITY OF CANCER CHEMOTHERAPY | PHARMACIA & UPJOHN COMPANY (US) | 2000-09-06 | — | — | EP | claimed |
| US-6069145-A | AGAINST ANTIBIOTIC RESISTANT BACTERIA | ZENECA LIMITED (GB) | 2000-05-30 | — | — | US | claimed |
| US-6040306-A | Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy | PHARMACIA & UPJOHN COMPANY | 2000-03-21 | — | — | US | claimed |
| WO-1999025344-A1 | USE OF OXAZOLIDINONE DERIVATIVES FOR TREATING PSORIASIS, ARTHRITIS AND REDUCING THE TOXICITY OF CANCER CHEMOTHERAPY | PHARMACIA & UPJOHN COMPANY (US) | 1999-05-27 | — | — | WO | claimed |
| EP-0882041-A1 | PIPERAZINONEPHENYLOXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | AstraZeneca AB (SE) | 1998-12-09 | — | — | EP | claimed |
| WO-1997027188-A1 | PIPERAZINONEPHENYLOXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | ZENECA LIMITED (GB) | 1997-07-31 | — | — | WO | claimed |